112 related articles for article (PubMed ID: 23328173)
1. [Salvage chemotherapy for advanced testicular cancer].
Nakamura T; Miki T
Hinyokika Kiyo; 2012 Dec; 58(12):721-5. PubMed ID: 23328173
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.
Nonomura N; Oka D; Nishimura K; Nakayama M; Inoue H; Mizutani Y; Miki T; Okuyama A
Int J Urol; 2007 Jun; 14(6):527-31. PubMed ID: 17593098
[TBL] [Abstract][Full Text] [Related]
3. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
[TBL] [Abstract][Full Text] [Related]
4. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
Park S; Lee S; Lee J; Park SH; Park JO; Kang WK; Park YS; Lim HY
Onkologie; 2011; 34(8-9):416-20. PubMed ID: 21934340
[TBL] [Abstract][Full Text] [Related]
5. Recent strategy for the management of advanced testicular cancer.
Nakamura T; Miki T
Int J Urol; 2010 Feb; 17(2):148-57. PubMed ID: 20377835
[TBL] [Abstract][Full Text] [Related]
6. [Current status and future perspectives in chemotherapy for testicular cancer].
Kawai K
Gan To Kagaku Ryoho; 2003 Feb; 30(2):171-80. PubMed ID: 12610862
[TBL] [Abstract][Full Text] [Related]
7. [High-dose chemotherapy for advanced testicular germ cell tumors].
Miyake H; Fujisawa M
Hinyokika Kiyo; 2012 Dec; 58(12):731-5. PubMed ID: 23328175
[TBL] [Abstract][Full Text] [Related]
8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
[TBL] [Abstract][Full Text] [Related]
10. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
Kondagunta GV; Bacik J; Donadio A; Bajorin D; Marion S; Sheinfeld J; Bosl GJ; Motzer RJ
J Clin Oncol; 2005 Sep; 23(27):6549-55. PubMed ID: 16170162
[TBL] [Abstract][Full Text] [Related]
11. [Salvage chemotherapy in refractory testicular cancer].
Nakao M; Nomoto T; Mizutani Y; Miki T
Gan To Kagaku Ryoho; 2000 Apr; 27(4):542-7. PubMed ID: 10790996
[TBL] [Abstract][Full Text] [Related]
12. [Verification of testicular cancer guidelines].
Nonomura N; Azuma H
Hinyokika Kiyo; 2012 Dec; 58(12):713-4. PubMed ID: 23328171
[TBL] [Abstract][Full Text] [Related]
13. [Results of chemotherapy and salvage surgery for advanced testicular cancer].
Saiki S; Meguro N; Maeda O; Kinouchi T; Kuroda M; Usami M; Kotake T; Miki T
Hinyokika Kiyo; 1999 Nov; 45(11):777-81. PubMed ID: 10637743
[TBL] [Abstract][Full Text] [Related]
14. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.
Lorch A; Bascoul-Mollevi C; Kramar A; Einhorn L; Necchi A; Massard C; De Giorgi U; Fléchon A; Margolin K; Lotz JP; Germà-Lluch JR; Powles T; Kollmannsberger C; Beyer J
J Clin Oncol; 2011 Jun; 29(16):2178-84. PubMed ID: 21444870
[TBL] [Abstract][Full Text] [Related]
15. The role of ifosfamide in the treatment of testicular and urothelial malignancies.
Roth BJ
Semin Oncol; 1996 Jun; 23(3 Suppl 7):19-27. PubMed ID: 8711497
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience.
Motzer RJ; Bajorin DF; Vlamis V; Weisen S; Bosl GJ
Semin Oncol; 1992 Dec; 19(6 Suppl 12):8-11. PubMed ID: 1336624
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors.
Farmakis D; Pectasides M; Pectasides D
Eur Urol; 2005 Sep; 48(3):400-7. PubMed ID: 15964136
[TBL] [Abstract][Full Text] [Related]
19. [Salvage therapy for refractory testicular cancer].
Kawai K; Akaza H
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1129-35. PubMed ID: 8751799
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
Hartmann JT; Gauler T; Metzner B; Gerl A; Casper J; Rick O; Horger M; Schleicher J; Derigs G; Mayer-Steinacker R; Beyer J; Kuczyk MA; Bokemeyer C;
J Clin Oncol; 2007 Dec; 25(36):5742-7. PubMed ID: 18089869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
